Page 24 - Mark Berger News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SHARE Photo courtesy of siam.pukkato@gmail.com via Getty Images Modern portfolio theory (MPT) is a fundamental wealth management strategy that won the Nobel Prize in economics in 1990. There are three components of MPT: Pick a fully diversified portfolio—meaning stocks and bonds, U.S. and foreign, small and large companies, etc. Implement your portfolio with diversified, low-cost investments. Rebalance the portfolio on a regular basis. As straightforward as it sounds, sticking with this strategy can be difficult since an investor is never completely concentrated where things are doing ...

Villa Steps Up to Show Appreciation for Staff Heroes: New Villa Hero Foundation Formed for “Heroes Helping Heroes” Share Article Throughout the trauma and challenges of the COVID-19 pandemic, employees of Villa Healthcare have worked tirelessly to serve nursing home residents every day. To show appreciation for that hero-level commitment, Villa stepped up to create several initiatives to recognize employees’ contributions on the front lines of health care. “We wanted to thank our employees for their unwavering commitment to our residents throughout this pandemic. They are all heroes,�...

Nursing home residents and staff in Terrebonne and Lafourche have received the first round of coronavirus vaccines, officials said.

Nursing homes, senior citizen advocates say COVID-19 vaccinations will boost optimism Nursing homes ready for second dose of vaccines By Sabrina Wilson | January 5, 2021 at 7:54 PM CST - Updated January 5 at 9:17 PM NEW ORLEANS (WVUE) - The nursing home industry as well as advocates for senior citizens living outside of long-term care facilities are thrilled vaccinations among older Louisianans are increasing. And they believe access to the shots will improve the emotional outlook of many people. Deacon Jeff Tully is the CEO of the Notre Dame Health System which is a ministry of the Arch...

Actinium Says DMC Recommends Phase 3 SIERRA Trial Continue To Full Enrolment Of 150 Patients WASHINGTON (dpa-AFX) - Actinium Pharmaceuticals, Inc. (ATNM) said Tuesday that the independent Data Monitoring Committee or DMC has completed the single ad hoc interim analysis of the pivotal Phase 3 SIERRA study of Iomab-B for bone marrow transplant (BMT) conditioning in patients aged above 55 with active relapsed or refractory Acute Myeloid Leukemia (R/R AML). The SIERRA trial is a randomized, controlled study evaluating outcomes of patients receiving Iomab-B and a BMT compared to outcomes of patien...